Published in Int J Lepr Other Mycobact Dis on August 23, 1976
The continuing challenges of leprosy. Clin Microbiol Rev (2006) 4.09
Analysis of naturally occurring delayed-type hypersensitivity reactions in leprosy by in situ hybridization. J Exp Med (1989) 1.82
Divergence of macrophage phagocytic and antimicrobial programs in leprosy. Cell Host Microbe (2009) 1.55
Tumor necrosis factor production in patients with leprosy. Infect Immun (1992) 1.55
Understanding the type 1 reactional state for early diagnosis and treatment: a way to avoid disability in leprosy. An Bras Dermatol (2013) 1.14
Expression of adhesion molecules in leprosy lesions. Infect Immun (1991) 1.05
Selection of T lymphocytes bearing limited T-cell receptor beta chains in the response to a human pathogen. Proc Natl Acad Sci U S A (1993) 1.01
Serum and tissue lysozyme in leprosy. Infect Immun (1977) 0.95
Epidermal keratinocyte Ia expression, Langerhans cell hyperplasia and lymphocytic infiltration in skin lesions of leprosy. Clin Exp Immunol (1986) 0.93
Cell-type deconvolution with immune pathways identifies gene networks of host defense and immunopathology in leprosy. JCI Insight (2016) 0.75
A rapid slide-agglutination method for typing pneumococci by means of specific antibody adsorbed to protein A-containing staphylococci. J Med Microbiol (1973) 10.31
New method for the serological grouping of Streptococci with specific antibodies adsorbed to protein A-containing staphylococci. Infect Immun (1973) 7.92
Sensitivity and specificity of PCR for detection of Mycobacterium tuberculosis: a blind comparison study among seven laboratories. J Clin Microbiol (1994) 5.84
Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population. J Clin Microbiol (1994) 4.95
Differences in anti-protein A activity among IgG subgroups. J Immunol (1969) 4.56
Slide agglutination method for the serological identification of Neisseria gonorrhoeae with anti-gonococcal antibodies adsorbed to protein A-containing staphylococci. Appl Microbiol (1974) 4.17
Phylogenetic insight into evolution of mammalian Fc fragment of gamma G globulin using staphylococcal protein A. J Immunol (1970) 3.84
Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection. Lancet (2001) 3.71
Purification and some properties of streptococcal protein G, a novel IgG-binding reagent. J Immunol (1984) 3.56
A surface component in group A, C, and G streptococci with non-immune reactivity for immunoglobulin G. J Immunol (1973) 3.23
Effect of clonal and serotype-specific properties on the invasive capacity of Streptococcus pneumoniae. J Infect Dis (2004) 3.14
Differential staining of bacteria in clinical specimens using acridine orange buffered at low pH. Acta Pathol Microbiol Scand B (1977) 2.94
Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values. Clin Microbiol Infect (2006) 2.82
A rountine diagnostic test for IgA and IgM antibodies to rubella virus: absorption of IgG with Staphylococcus aureus. J Infect Dis (1974) 2.67
Definition of staphylococcal protein A reactivity for human immunoglobulin G fragments. Immunochemistry (1970) 2.61
Antiphagocytic effects of staphylococcal protein A. J Immunol (1969) 2.59
Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine. Infect Immun (1995) 2.44
Protein A reactivity with mouse immunoglobulins. Structural relationship between some mouse and human immunoglobulins. J Immunol (1970) 2.38
Characterization and nucleotide sequence of a Klebsiella oxytoca cryptic plasmid encoding a CMY-type beta-lactamase: confirmation that the plasmid-mediated cephamycinase originated from the Citrobacter freundii AmpC beta-lactamase. Antimicrob Agents Chemother (1999) 2.27
Antibody response in rabbits to immunization with Mycobacterium leprae. Infect Immun (1977) 2.21
The use of protein A-containing Staphylococcus aureus as a solid phase anti-IgG reagent in radioimmunoassays as exemplified in the quantitation of alpha-fetoprotein in normal human adult serum. Eur J Immunol (1974) 2.19
Quantitation of staphylococcal protein A: Determination of equilibrium constant and number of protein A residues on bacteria. J Immunol (1970) 2.19
Heterogeneity of nonimmune immunoglobulin Fc reactivity among gram-positive cocci: description of three major types of receptors for human immunoglobulin G. Infect Immun (1977) 2.15
Production, characterization and control of MenB-vaccine "Folkehelsa": an outer membrane vesicle vaccine against group B meningococcal disease. NIPH Ann (1991) 2.13
Lymphocyte transformation test in leprosy; correlation of the response with inflammation of lesions. Clin Exp Immunol (1976) 2.08
Specific absorption of human serum albumin, immunoglobulin A, and immunoglobulin G with selected strains of group A and G streptococci. Infect Immun (1979) 1.92
Lipoteichoic acid is the major cell wall component responsible for surface hydrophobicity of group A streptococci. Infect Immun (1983) 1.89
Preliminary taxonomic studies on the leprosy bacillus. Br J Exp Pathol (1975) 1.83
Resistance of multidrug-resistant strains of Mycobacterium tuberculosis from the Archangel oblast, Russia, to second-line anti-tuberculosis drugs. Eur J Clin Microbiol Infect Dis (2005) 1.80
Antibiotic medication and bacterial resistance to antibiotics: a survey of children in a Vietnamese community. Trop Med Int Health (2000) 1.72
Fibrinogen binding structures in beta-hemolytic streptococci group A, C, and G. Comparisons with receptors for IgG and aggregated beta 2-microglobulin. Acta Pathol Microbiol Scand B (1979) 1.70
Bactericidal antibodies after vaccination with the Norwegian meningococcal serogroup B outer membrane vesicle vaccine: a brief survey. NIPH Ann (1991) 1.68
Cross-reactions between mycobacteria. II. Crossed immunoelectrophoretic analysis of soluble antigens of BCG and comparison with other mycobacteria. Scand J Immunol (1979) 1.67
Immune complexes and complement hypercatabolism in patients with leprosy. Clin Exp Immunol (1976) 1.66
Mycobacterium leprae specific antibodies detected by radioimmunoassay. Scand J Immunol (1978) 1.61
The effect of decentralisation on tuberculosis services in three states of Sudan. Int J Tuberc Lung Dis (2003) 1.59
Studies of mycobacterial antigens, with special reference to Mycobacterium leprae. Infect Immun (1976) 1.55
Phytohaemagglutinin-induced lymphocyte transformation in leprosy. Clin Exp Immunol (1971) 1.54
Binding of aggregated human beta2-microglobulin to surface protein structure in group A, C, and G streptococci. Infect Immun (1978) 1.53
The protective role of antibody responses during Mycobacterium tuberculosis infection. Clin Exp Immunol (2009) 1.48
Demonstration of specific binding sites for human serum albumin in group C and G streptococci. Infect Immun (1980) 1.46
Immune responses against major outer membrane antigens of Neisseria meningitidis in vaccinees and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial. Infect Immun (1998) 1.46
Evaluating an active case-finding strategy to identify smear-positive tuberculosis in rural Ethiopia. Int J Tuberc Lung Dis (2009) 1.44
Experimental and clinical studies on rifampicin in treatment of leprosy. Br Med J (1970) 1.43
Effects of additional dietary gluten on the small-intestinal mucosa of volunteers and of patients with dermatitis herpetiformis. Scand J Gastroenterol (1987) 1.39
Integrons and gene cassettes in clinical isolates of co-trimoxazole-resistant Gram-negative bacteria. Clin Microbiol Infect (2005) 1.39
Progress in serodiagnosis of Mycobacterium tuberculosis infection. Scand J Immunol (2007) 1.37
Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia. Int J Tuberc Lung Dis (2002) 1.37
The emergence of Beijing family genotypes of Mycobacterium tuberculosis and low-level protection by bacille Calmette-Guérin (BCG) vaccines: is there a link? Clin Exp Immunol (2006) 1.33
Receptors for human plasminogen on gram-negative bacteria. Infect Immun (1990) 1.33
In vitro lymphocyte stimulation in leprosy; simultaneous stimulation with Mycobacterium leprae antigens and phytohaemagglutinin. Clin Exp Immunol (1979) 1.31
Treatment results of DOTS in 1797 Sudanese tuberculosis patients with or without HIV co-infection. Int J Tuberc Lung Dis (2002) 1.30
Dermatitis herpetiformis: diagnosis, diet and demography. Gut (1984) 1.28
Invasive disease caused by Haemophilus influenzae in Sweden 1997-2009; evidence of increasing incidence and clinical burden of non-type b strains. Clin Microbiol Infect (2011) 1.27
Prevalence of pulmonary tuberculosis and associated risk factors in Eastern Ethiopian prisons. Int J Tuberc Lung Dis (2011) 1.27
Activation and inhibition of IgG mediated complement fixation by staphylococcal protein A. Clin Exp Immunol (1970) 1.27
Spontaneous regression of human melanoma/nonmelanoma skin cancer: association with infiltrating CD4+ T cells. World J Surg (1995) 1.26
Small-intestinal immunoglobulin levels in dermatitis herpetiformis. Lancet (1972) 1.24
Mycobacterial antigens in antibody responses of leprosy patients. Int J Lepr Other Mycobact Dis (1976) 1.23
Tissue-type plasminogen activator-mediated activation of plasminogen on the surface of group A, C, and G streptococci. Infect Immun (1992) 1.23
Human leprosy in normal mice. Br Med J (1969) 1.22
Immunocytochemical analysis of the cellular infiltrate in primary regressing and non-regressing malignant melanoma. J Invest Dermatol (1991) 1.22
Psychosocial determinants of sexual activity and condom use intention among youth in Addis Ababa, Ethiopia. Int J STD AIDS (2002) 1.21
Sulphone resistance in leprosy. A review of one hundred proven clinical cases. Lancet (1975) 1.20
Late-onset atopic eczema and multiple food allergies after infectious mononucleosis. Br Med J (Clin Res Ed) (1981) 1.20
Antigenic heterogeneity in patients with reactions in borderline leprosy. Br Med J (1975) 1.18
Characteristics of serogroup A Neisseria meningitidis responsible for an epidemic in Ethiopia, 1988-89. Scand J Infect Dis (1990) 1.18
Relation of grading of sputum smears with clinical features of tuberculosis patients in routine practice in Sudan. Int J Tuberc Lung Dis (2002) 1.17
A mouse model for slowly progressive primary tuberculosis. Scand J Immunol (1999) 1.16
Antimicrobial susceptibility testing in Sweden. II. Species-related zone diameter breakpoints to avoid interpretive errors and guard against unrecognized evolution of resistance. Scand J Infect Dis Suppl (1997) 1.16
Evidence for prevention of borderline leprosy reactions by dapsone. Lancet (1976) 1.15
Regression in basal cell carcinoma: an immunohistochemical analysis. Br J Dermatol (1994) 1.15
Plasma factors in delayed-type hypersensitivity. Augmentation of lymphocyte responses in borderline leprosy reactions. Clin Exp Immunol (1976) 1.15
Extended spectrum beta-lactamase from Klebsiella oxytoca, not belonging to the TEM or SHV family. J Antimicrob Chemother (1992) 1.15
Reactions between certain strains of pneumococci and Fc of IgG. J Immunol (1974) 1.14
Hospital-acquired infections among surgical patients in Tikur Anbessa Hospital, Addis Ababa, Ethiopia. Am J Infect Control (1988) 1.13
Depressive effect of serum from patients with leprosy on mixed lymphocyte reactions. Influence of anti-leprosy treatment. Clin Exp Immunol (1975) 1.13
Some aspects of the relations between rheumatoid arthritis, antigamma-globulin factors and the polymorphism of human gamma globulin. Ann N Y Acad Sci (1965) 1.12
Etiology of pneumonia, sepsis and meningitis in infants younger than three months of age in Ethiopia. Pediatr Infect Dis J (1999) 1.12
Comparison among opsonic activity, antimeningococcal immunoglobulin G response, and serum bactericidal activity against meningococci in sera from vaccinees after immunization with a serogroup B outer membrane vesicle vaccine. Infect Immun (1995) 1.10
Binding of plasminogen to Neisseria meningitidis and Neisseria gonorrhoeae and formation of surface-associated plasmin. J Infect Dis (1992) 1.10
The plasminogen activator inhibitor-2 gene is not required for normal murine development or survival. Proc Natl Acad Sci U S A (1999) 1.09
Comparative studies of antigen 21 in Mycobacterium and Nocardia species: possible taxonomic relationships with Mycobacterium leprae. Infect Immun (1980) 1.09
Evaluation of cell mediated immune responses in untreated cases of leprosy. Clin Exp Immunol (1972) 1.09
Capacity of group A, B, C, D, and G streptococci to agglutinate sensitized sheep red cells. Acta Pathol Microbiol Scand B Microbiol Immunol (1974) 1.09
Criteria for the safe avoidance of needle sampling in young women with solid breast masses. Clin Radiol (2010) 1.08
Immunoglobulin-binding structure on bovine group G streptococci different from type III Fc receptors on human group G streptococci. Infect Immun (1979) 1.08
Antibodies against BCG antigen 60 in mycobacterial infection. Br Med J (1977) 1.08